The phenomenon of molecular mimicry was found previously for Citrobacter braakii O37, which shared epitopes with human and horse erythrocytes. The aim of this study was to elucidate the basis of the serological cross-reactivity between anti-C. braakii O37 serum and human erythrocytes. The experiments involved analyzing the epitope on the human erythrocyte membrane, that could be recognized by affinity-purified antibodies. The results indicated a specific glycoprotein fraction in immunoblotting, namely band 3, which interacted with the antibodies purified on lipopolysaccharide from C. braakii O37 LPS (LPS O37) and its core affinity columns. Treating the erythrocytes with trypsin, which cleaves glycophorin A, improved the agglutination because band 3 became more available for antibody binding. Isolated band 3 immobilized on an affinity plate could be used to purify antibodies from the anti-C. braakii O37 serum. These antibodies showed a specific reactivity to LPS O37, but not to the related lipopolysaccharide from Salmonella Toucra O48. Furthermore, the inhibition of agglutination with lactose, the diminished interaction of the specific antibodies purified on LPS O37 with endo-b-galactosidase-treated band 3, and the reactivity of these antibodies to the 40-kDa fragment of band 3 but not to its trypsin-elaborated 60-kDa fragment, all indicated that the epitope is located on the N-glycan of band 3.
Introduction
The term 'molecular mimicry' was introduced in 1964 by Damian, who stated that the antigenic determinants of microorganisms may resemble antigenic determinants of the host (Damian, 1964) . Subsequently, such mimicry may obviate the development of an immune response to the microorganism, thereby protecting it from the host defense. Molecular mimicry has been assumed not only as protection for the microorganism in the host tissues but also as a factor that may elicit an autoimmune response, causing harm to the host (Korzeniowska-Kowal et al., 2001) . Molecular mimicry of host structures by lipopolysaccharides is one of the most important pathogenic factors of several medically significant bacteria and is defined as a structural similarity of microbial molecules to host tissue that contributes to pathogenicity (Rose & Mackay, 2000; Korzeniowska-Kowal et al., 2001) . Many studies showed that the lipopolysaccharide of such pathogens as Campylobacter jejuni, Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, and Helicobacter pylori mimic host structures (Moran et al., 1996) . The concept of molecular mimicry is based in part on available epidemiological and experimental evidence of an association between infectious agents and the presence of autoimmune disease and the observed cross-reactivity of self-antigens with microbial epitopes. This is obvious in such a case as H. pylori-associated disease (Moran et al., 1996) . On the other hand, some studies did not find enough evidence for a role of molecular mimicry in autoimmune diseases (Inman et al., 1986; Lahesmaa et al., 1993; Liang & Mamula, 2000; Rose & Mackay, 2000) .
Citrobacter braakii has been associated with cases of neonatal meningitis and brain abscess. It has also been reported that these bacteria are infrequent causes of infections in children. Although Citrobacter infections are not common among neonates, they are associated with a high risk of meningitis and CNS abscesses. The pathogenesis of Citrobacter infections is not well characterized (Badger et al., 1999; Doran, 1999) . Serological mimicry was found for C. braakii O37, which shared epitopes with horse and human erythrocytes, and this phenomenon may be correlated with the pathogenicity of this bacterium (Gamian et al., 1992) . The aim of the present study was to elucidate the basis of this serological cross-reactivity, especially between C. braakii O37 and human erythrocytes. This study showed that anti-C. braakii O37 antibodies recognized an epitope on the band 3 glycoprotein of human erythrocytes. Characterization of this epitope revealed that it was the N-glycan on the fourth loop of band 3. It was also shown that the antibody population that was affinity purified on immobilized core oligosaccharide of LPS O37 is more reactive with band 3 than those purified on the O-specific polysaccharide of the same LPS O37. Therefore, this study concluded that the cross-reactivity between human erythrocytes and C. braakii O37 is based on the recognition of the N-glycan-related epitope of band 3 by antibodies directed against the core oligosaccharides of C. braakii O37.
Materials and methods

Cultivation of bacteria and extraction of lipopolysaccharide
Citrobacter braakii serotype O37 strain PCM 2346 (C. freundii Be115/66, strain F. Kauffmann 2624/36) (Keleti et al., 1971; Lányi, 1984; Gamian et al., 1992; Miki et al., 1996) , obtained from the collection of the Institute of Immunology and Experimental Therapy (Wrocław, Poland), was originally from the Czech National Collection of Type Cultures, Prague. The bacteria were cultivated in liquid medium with aeration at 37 1C for 24 h, and then harvested and freeze-dried. Lipopolysaccharide was isolated by phenolwater extraction (Westphal & Jann, 1965) and purified by ultracentrifugation or on a Sepharose 2B column (Romanowska, 1970) as described previously (Gamian et al., 1992 (Gamian et al., , 1994 Lipiñski et al., 2002) . Mild acid hydrolysis of lipopolysaccharide and fractionation of the carbohydrate material by means of gel permeation chromatography on Bio-Gel P-4 (1.6 Â 100 cm) to obtain O-specific polysaccharide and core oligosaccharide were described previously (Gamian et al., 1994; Lipiñski et al., 2002) .
Preparation of erythrocyte membranes and isolation of band 3 from erythrocytes
Packed erythrocytes (10 mL) were washed with isotonic phosphate buffer, pH 7.4 (PBS). The erythrocytes were hemolyzed by adding 0.005 M phosphate buffer, pH 8.3, with phenyl methyl sulfonyl fluoride (0.001 M) as a proteinase inhibitor. The stroma was washed five times with a fresh buffer of the same ionic strength and the washed stroma, hemoglobin-free ghosts of erythrocytes, was suspended in PBS and maintained at À 70 1C.
Band 3 glycoprotein was isolated and purified as described by Tsuji et al. (1980) . Human erythrocytes of group O were used in all the experiments. The erythrocyte membranes were alkali-treated, solubilized with Triton-X 100, and fractionated on a Sepharose 6B column in the presence of sodium dodecyl sulfate (SDS). Fractions were tested in SDS-PAGE and the protein peak corresponding to band 3 was collected and then dialyzed, concentrated, and maintained at À 70 1C.
Treatment of erythrocytes and band 3 with enzymes
The treatment of intact erythrocytes with chymotrypsin and trypsin was performed as described previously (Lutz et al., 1984) . The washed packed red cells were incubated with chymotrypsin (Difco) in a concentration of 300 mg mL À1 at 37 1C for 90 min. The other 100 mL samples of the packed red cells were diluted in 1 mL of PBS and incubated with 100 mL of papain (Sigma) at 37 1C for 1 h. Treatment with pronase (Serva) was performed as described previously by Morrison et al. (1985) . The packed red cells diluted 1 : 10 with PBS were incubated with 100 mg mL À1 of pronase at 37 1C for 1 h. The treatment of erythrocytes with sialidase from Vibrio cholerae (1 U mg À1 ; Serva) was performed as described by Latron et al. (1987) . Treatment of band 3 with endo-b-galactosidase (Seikagaku Kogyo) was performed as described by Ando et al. (1996) . Briefly, band 3 (1 mg mL À1 )
was treated with endo-b-galactosidase (100 mU mL À1 ) in 0.1 M sodium acetate buffer, pH 5.8, containing 0.07 M NaCl and 0.02% NaN 3 at 37 1C for 96 h.
Preparation of affinity columns
To prepare affinity columns, Sepharose 4B gel was washed with water and the suspension was adjusted to pH 11.0 by 0.1 M NaOH. For activation of the gel, CNBr was added and the reaction was maintained for 30 min at a pH of 11.0 with 0.1 M NaOH drop-wise. The activated Sepharose 4B was washed several times with carbonate buffer, pH 7.5. Three affinity columns were prepared, namely with immobilized LPS O37 (LPS column), with the O-specific polysaccharide fraction of LPS O37 (PS column) and with the core oligosaccharide fraction from LPS O37 (OS column). LPS O37 in soluble form, its core oligosaccharide, or the O-specific polysaccharide were added to the activated Sepharose 4B gel and incubated at room temperature for 3 h with gentle shaking. The unbound reactive sites of the Sepharose 4B were blocked by 1 M ethanolamine at room temperature for 2 h and then the gel was washed extensively with PBS.
Immunization of rabbits and isolation of monospecific anti-C. braakii O37 antibodies
The generation of rabbit serum against whole bacterial cells was performed as described previously (Gamian et al., 1992) . Rabbits were immunized with an acetone-dried bacterial cell mass suspended in PBS, first with a subcutaneous dose of 100 mg dry cell mass. Then, rabbits were intravenously injected twice a week with the bacteria, in amounts doubling each time to 6400 mg mL À1 . One week after the last injection, the rabbits were bled and sera were collected and de-complemented by heating at 56 1C for 30 min. The sera were stored at À 20 1C.
To prepare immunoglobulins, a saturated ammonium sulfate solution, pH 7.8, was added to the whole serum (5 mL) and diluted with PBS to a final concentration of 33.3%. After constant stirring at room temperature for 3 h, it was centrifuged at 1400 g for 30 min and the precipitate was dissolved in PBS and dialyzed at 4 1C against the same buffer. The supernatant was assayed for protein concentration and stored for affinity purification of antibody.
Isolation of monospecific anti-C. braakii O37 antibodies on antigen coated on microtitration plates was performed according to Prabal et al. (2000) . LPS O37 or band 3 protein [10 mg in 100 mL of 10 mM tris-buffered saline (TBS), pH 7.2] was added to the wells of a U-bottomed microtitration plate, and then incubated at 5 1C overnight and washed three times with TBS-T (TBS containing 0.2% Tween 20). 1% bovine serum albumin (BSA) (100 mL) was added to the wells and the plates were further incubated at 37 1C for 1 h and then washed with TBS-T. The salted-out immunoglobulins (100 mL of 2 mg protein mL À1 ) were applied to the wells and incubated overnight at 4 1C, and then washed with TBS-T to remove nonspecifically bound antibodies. Citratephosphate buffer of pH 5.0 (100 mL well À1 ) was applied at 37 1C for 1 h to dissociate the specifically bound antibodies, which, in turn, were dialyzed against PBS and centrifuged. The clear supernatant was assayed for protein.
Isolation of monospecific anti-C. braakii O37 antibodies was also achieved by affinity chromatography on the column of Sepharose 4B conjugated with LPS O37. Diluted anti-C. braakii O37 serum (1 : 1 in PBS) was loaded onto the LPS O37 column at a slow rate. The column was washed with PBS until the disappearance of protein as monitored at 280 nm. Nonspecifically bound antibodies were washed out with 1 M NaCl. The specifically bound antibodies were eluted in 2-mL fractions by 3 M potassium thiocyanate (KSCN) with monitoring of absorbance at 280 nm. The chosen fractions were collected and extensively dialyzed overnight against PBS. Anti-C. braakii O37 antibodies were concentrated with a PM-10 membrane on Amicon and labeled as 'LPS-Abs' .
The isolation of monospecific anti-C. braakii O37 antibodies on band 3 immobilized to a polyvinylidene difluoride (PVDF) membrane by electrophoretic transfer was performed according to Lou et al. (1994) . Erythrocyte glycoproteins were separated by SDS-PAGE under reducing conditions. The proteins were electrophoretically transferred to PVDF membranes (Millipore). The membranes were reversibly stained with Ponceau red stain and pieces of the membrane corresponding to the band 3 glycoprotein were excised. Membrane pieces were rinsed in TBS-T (20 mM) and blocked with 2% BSA at 37 1C for 2 h, and then incubated with rabbit anti-C. braakii O37 serum at a 1 : 50 dilution in TBS-T at room temperature for 2 h. After washing for 10 min with TBS-T three times, the antibodies were eluted from the membranes with 0.1 M glycine-HCl (Sigma), pH 2.8, solution and dialyzed against PBS overnight at 4 1C.
Hemagglutination and inhibition of hemagglutination
Hemagglutination tests were carried out in U-well microtitration plates. Twenty microliters of serially diluted antibody was mixed with 20 mL of a 2% erythrocyte suspension and hemagglutination was read after a 2-h incubation at room temperature. Inhibition tests were carried out by preincubating 10 mL of anti-C. braakii O37 antibodies with an equal volume of serially diluted 1 M carbohydrate solutions at room temperature for 1 h before addition of 20 mL of a 2% human red cell suspension. Hemagglutination was read after 2 h incubation at room temperature. Several carbohydrates, including D-glucosamine, b-lactose (Sigma), L-and D-fucose, D-mannose, glucose-b-methyl pyranoside, galactose-b-methyl pyranoside (Koch Light), and D-galactose (Merck), were examined. The inhibitory activity was expressed as the lowest concentration of the inhibitor, which shows complete inhibition of agglutination after incubation with an equal volume of antibody solution of titer 4.
SDS-PAGE and immunoblotting
Polyacrylamide gel electrophoresis in the presence of SDS was carried out in 10% gel according to the method of Laemmli (1970) as described previously (Gamian et al., 1992) . Erythrocyte membranes were fractionated by SDS-PAGE and the gels were stained with Coomassie brilliant blue (CBB). For immunoblotting, the proteins were electrophoretically transferred at 100 mA for 1 h to an Immobilon P membrane (Towbin et al., 1979; Lipiñski et al., 2002) . The membrane was blocked at 36 1C for 1 h with 2% (w/v) BSA-T. Then, the blot was incubated for 2 h with serum diluted 1 : 200. The membrane was washed twice with TBS buffer for 20 min before incubation for 1 h with goat anti-rabbit IgG antibodies conjugated with alkaline phosphatase (AP) diluted 1 : 3000 in TBS-T. The blot was stained in 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and phosphate/nitroblue tetrazolium (NBT).
Dot blotting
A nitrocellulose membrane was washed in water and then left for 1 h to dry. The soluble antigen (1 mL of 2 mg mL À1 ) was applied to the membrane and incubated for 8 min. The membrane was washed three times with PBS and then blocked with 1% BSA for 15 min. Then, the membrane was incubated for 5 min with monospecific anti-C. braakii O37 antibodies. After washing, the membrane was incubated with goat anti-rabbit IgG antibodies conjugated with horseradish peroxidase (HRP) for 20 min. Finally, the membrane was washed five times with PBS and the reaction was developed by adding a substrate. All the steps of this method were carried out at room temperature.
ELISA on plates coated with erythrocytes
These experiments were performed as described by Shan et al. (1998) . A flat-bottomed microtiter plate (Nalgene Nunc International Roskilde, Denmark) was coated with a poly-L-lysine solution (20 mg mL À1 in PBS, 50 or 100 mL well À1 ). After washing, the plate was incubated with erythrocytes at room temperature for 1 h. The plate was then centrifuged at 179 g for 2 min. The erythrocytes were fixed by the addition of 0.25% glutaraldehyde. The plate was blocked with 0.1 M glycine for 1 h, and then washed with TBS-T (200 mL well À1 ). Antibodies diluted in TBS-T were incubated at room temperature for 2 h and the plate was washed with TBS-T. Horseradish-peroxidase conjugated with a goat anti-rabbit IgG antibody was added and kept at room temperature for 1 h, and then the plate was washed with TBS-T. Substrate o-phenylenediamine (OPD) (100 mL) was added to the plates and the reaction was stopped with 4 M H 2 SO 4 . The OD was monitored by measuring the absorption at 492 nm using a Behring EL311 microplate reader.
ELISA on plates coated with lipopolysaccharide ELISA was performed for bacterial lipopolysaccharide according to the method of Prabal et al. (2000) with some modifications. The wells of flat-bottomed microtiter plates (Nunc) were coated with lipopolysaccharide suspended in PBS, pH 7.2 (2 mg in 100 mL well À1 ), at 37 1C for 3 h and then at 4 1C overnight. The coated plates were washed three times with distilled water. The residual binding capacity of the plates was blocked by 0.2% casein in TBS buffer containing 0.05% Tween 20, pH 7.5 (TBS-T), at room temperature for 10 min. Thereafter, the plates were washed again with water and the primary antibodies in serial dilutions with TBS-T were added and incubated at room temperature for 2 h. After washing with water, blocking buffer, and water once again, the conjugate of goat anti-rabbit IgG antibody with AP (50 mL) (Bio-Rad) was added and incubated at room temperature for 1 h. Following washing, 100 mL of the alkaline phosphatase substrate, pH 9.8, was added. The OD was measured at 405 nm using a microplate reader.
Results
Effect of enzymes and sugars on the agglutination of erythrocytes with anti-C. braakii O37 serum
The agglutination of the human erythrocytes by anti-C. braakii O37 serum was enhanced by treating the erythrocytes with sialidase, trypsin, pronase, and papain, while treatment with chymotrypsin did not show a significant effect, and pepsin treatment decreased the agglutination titer (Table 1 ). The highest increase in agglutination titer was observed after trypsin treatment. In a control experiment, sera produced against other enterobacterial sialic acid-containing strains (Salmonella Toucra O48, Escherichia coli O104, O56 and O24 and Hafnia alvei PCM 1186) did not agglutinate human erythrocytes before and after their treatment with trypsin. Moreover, treating sheep erythrocytes with trypsin did not improve their trace agglutination by anti-C. braakii O37 serum (data not shown). These results implied that glycophorin A, which can be cleaved by trypsin (Rasamoelisole et al., 1997) , masked the epitope recognized by anti-C. braakii O37 antibodies and, when removed by trypsin, the epitope became more available to these antibodies. The enhancement of agglutination by treating human erythrocytes with trypsin, pronase, and papain suggested that anti-C. braakii O37 antibodies may recognize a carbohydrate epitope. Therefore, inhibition of agglutination with different saccharides was performed. The results, presented in Table 2 , showed that lactose and b-methyl- galactopyranoside (Gal-b-Me) significantly inhibited the agglutination of human erythrocytes with anti-C. braakii O37 serum. Inhibition with lactose was also achieved on immunoblot of human erythrocyte membrane with this serum (not shown).
Reactivity of anti-C. braakii O37 antibodies with human erythrocyte membrane proteins
Monospecific anti-C. braakii O37 antibodies were affinity purified by several methods in order to characterize the components of human erythrocytes carrying the crossreacting epitope. Isolation of the antibodies specific to LPS O37 was carried out by two affinity methods, namely on microtitration plates and on affinity columns. Antibodies purified on 96-well titration plates coated with LPS O37 were called 'LPS-96Abs', while those purified on the LPS O37 affinity column were called 'LPS-Abs'. The results of the immunoblotting, shown in Fig. 1 (lane 1), indicate that LPS-96Abs showed reactivity with the band 3 glycoprotein of the human erythrocyte membrane. Furthermore, the LPS-Abs strongly reacted with band 3 on immunoblots (Fig. 1, lane 2) . The 40-kDa fragment of band 3 was also recognized by the LPS-Abs. The observation that these antibodies agglutinated the human erythrocytes suggested that an extracellular portion of the band 3 glycoprotein was recognized.
In the immunoblotting assay, reactivity was also observed for the band 4.1 protein of the human erythrocyte membrane (Fig. 1, lane 1) . To address whether band 4.1 has any role in this reactivity, membranes were tested against a fraction of antibodies that was eluted by 1 M NaCl from the lipopolysaccharide affinity column. Interestingly, these antibodies reacted with band 4.1, but not with band 3 (Fig. 1,  lane 3) , which indicates the presence of a separate population of anti-C. braakii O37 antibodies interacting specifically with band 4.1.
Reactivity of anti-C. braakii O37 antibodies with erythrocytes of different ABO blood groups
The results obtained from immunoblotting showed that the epitope recognized by anti-C. braakii O37 antibodies could be on the band 3 glycoprotein. Laine & Rush (1988) found that the majority of ABH blood group substances are present on the sugar domain of the band 3 glycoprotein. Therefore, blood samples of ABO groups were tested in agglutination and ELISA with anti-C. braakii O37 serum and with the affinity-purified antibodies (LPS-Abs). Analysis by ELISA revealed that the epitope recognized by LPS-Abs on human erythrocytes is ABO blood group independent. The binding curves of these purified antibodies with erythrocytes of different blood groups are highly similar (Fig. 2a) . The same results were obtained in agglutination reactions, because no differences in agglutination titers were obtained for any of them (data not shown).
Furthermore, in order to characterize the reactivity of the LPS-Abs with the membrane proteins of the different blood groups, the solubilized membranes obtained from these erythrocytes were subjected to SDS-PAGE and immunoblotting. The results, presented in Fig. 2b , show that the LPS-Abs recognized the same epitope, namely the band 3 glycoprotein, in the erythrocyte membranes of the A, B, and O blood groups, corroborating the ELISA results.
Reactivity of different populations of anti-C. braakii O37 antibodies with band 3
In order to fractionate the different antibody populations possibly existing in rabbit serum induced by whole bacterial cells, these populations could be isolated by different affinity columns with immobilized fragments of LPS O37. The polysaccharide and core oligosaccharide obtained by gel filtration on Bio-Gel P-4 of the carbohydrate material from hydrolyzed LPS O37 were separately immobilized to CNBractivated Sepharose 4B. The monospecific anti-C. braakii O37 antibodies purified on these columns with immobilized core oligosaccharide or O-specific polysaccharide were called 'Core-Abs' and 'PS-Abs', respectively. Both antibody populations were tested against the erythrocyte membranes in immunoblotting assay. The Core-Abs expressed a strong reactivity with the band 3 glycoprotein of the human erythrocyte membrane (Fig. 3, lane 2) . Weak bands in the 40-kDa region appeared as well, which may result from the degradation products of band 3 glycoprotein, according to Czerwiński et al. (1988) . In the same blot, these Core-Abs showed a strong specific reactivity with the low-molecularmass core region of LPS O37 (Fig. 3 , lane 1) and with some bands of high-molecular-mass LPS O37. However, antibodies purified on the O-specific polysaccharide affinity column did not show any reactivity with human erythrocyte glycoproteins (data not shown).
The results obtained so far showed that band 3 glycoprotein could be recognized by anti-C. braakii O37 antibodies purified by the LPS O37 affinity column (LPS-Abs), LPS O37 coated on the 96-well plates (LPS-96Abs), and the core oligosaccharide column (Core-Abs). In order to prove these observations, band 3 was then isolated from the alkalitreated red blood cell stroma and purified on the Sepharose 6B column (Fig. 4) and then coated onto 96-well plates and also immobilized onto a PVDF membrane for purifying specific antibodies. The anti-C. braakii O37 antibodies that were purified on immobilized band 3 using the 96-well plates and PVDF membrane showed specific reactivity to LPS O37, but not to the related Salmonella LPS O48 (Fig. 5) . Therefore, band 3 could be applied to purify antibodies with a specificity to LPS O37, which confirmed the cross-reactivity. After concentration, a sample of isolated band 3 glycoprotein was dissolved in a citrate-phosphate buffer, pH 6.0, and incubated with endo-b-galactosidase. As a control, another portion of the band 3 glycoprotein was incubated without enzyme under the same conditions. The band 3 preparations were serially diluted and applied to a nitrocellulose membrane. The monospecific antibodies (LPS96Abs) reacted more strongly with the untreated than with the endo-b-galactosidase-treated band 3 (Fig. 6) . Endo-bgalactosidase specifically cleaves poly-N-acetyllactosaminyl sugar chains. In the case of band 3, its N-linked sugar chains are long, branched poly-N-acetyllactosamine structures, and so this enzyme cleaves it only partially. This experiment showed the significant role of the glycan domain of band 3 in the binding of anti-C. braakii O37 antibodies to human erythrocytes.
Reactivity of anti-C. braakii O37 antibodies to proteins of trypsin-treated erythrocytes
The intact red cells were digested with trypsin as detailed in 'Materials and methods'. The enzyme reactivity was stopped by adding phenylmethanesulphonylfluoride and extensive washing with PBS. As shown in Fig. 7a (lane 2) , treatment of the intact erythrocytes with trypsin generated a 60-kDa fragment from the band 3 glycoprotein. The membranes obtained from the trypsin-treated erythrocytes showed a reduced amount of intact band 3 protein and an increased amount of the 60-kDa fragment, whereas the intensities of the 40-and 20-kDa fragments were similar to those from the membranes of untreated cells. Fig. 7b (lane 2) shows that the LPS-Abs reacted with the intact band 3 and its 40-kDa fragment, while no reactivity was observed with the 60-kDa fragment of the band 3 glycoprotein. The N-terminal 60-kDa fragment of band 3, which traverses the cell membrane, is not glycosylated (Czerwiński et al., 1988) and most carbohydrates are present on the 40-kDa fragment (Drickamer, 1978; Fukuda et al., 1979) . This experiment corroborates data that the monospecific anti-C. braakii O37 antibodies interact with the N-linked sugar chain of the band 3 glycoprotein.
Discussion
It has been shown that many medically significant bacteria mimic host structures (Moran et al., 1996) . Mimicry of host structures by lipopolysaccharide has been reported to contribute to the pathogenesis of several bacteria. Serological mimicry was found for C. braakii O37, which shared a common epitope with both horse and human erythrocytes (Gamian et al., 1992) . This mimicry may be correlated with the pathogenicity of these bacteria. The results of the present work allowed the identification of the extracellular epitope on the human erythrocyte recognized by anti-C. braakii O37 antibodies.
In the present study, the antibodies purified on immobilized LPS O37 (LPS-Abs) and its core oligosaccharide (CoreAbs) from the anti-C. braakii O37 serum recognized band 3 and its 40-kDa fragment of human erythrocyte membrane. This epitope should be exposed on the extracellular portion of band 3 because the same antibodies could agglutinate human red blood cells. Treatment of intact erythrocytes with chymotrypsin cleaves the membrane domain of band 3 after Tyr-553 (Steck, 1978; Poole, 2000) and Leu-558 (on the third loop) (Jennings et al., 1984; Reithmeier, 1993) . However, chymotrypsin did not change the agglutination titer with anti-C. braakii O37 antibodies, which suggested that the third extracellular loop of band 3 was not involved in the binding of anti-C. braakii O37 antibodies. Therefore, the fourth extracellular loop of band 3, including the N-glycan, could carry the epitope recognized by anti-C. braakii O37 antibodies.
Agglutination was significantly improved after treatment of the intact human erythrocytes with trypsin. Poole (2000) reported that glycophorin A (GPA), which has the same high abundance as band 3 on the erythrocyte surface, is susceptible to cleavage by trypsin at amino acids 30, 31, and 39.
Band 3 of human erythrocytes is more resistant to trypsin, while this enzyme cleaves GPA (Rasamoelisole et al., 1997) . Therefore, cleavage of GPA by trypsin most likely made band 3 more available for antibody binding. On the other hand, treatment of human erythrocytes with trypsin did not improve the low reactivity with anti-S. Toucra O48 serum, and sheep erythrocytes treated with trypsin, did not demonstrate agglutination by anti-C. braakii O37 antibodies. Because the agglutination was improved after treatment with trypsin, which cleaves GPA, and was not affected by chymotrypsin, which cleaves the third loop of band 3, the anti-C. braakii O37 antibodies could be directed to the large-branched N-linked sugar chain on the fourth exoplasmic loop of band 3. To address this question, inhibition of agglutination with different simple sugars was performed as the first step, and then immunoblotting of membranes from trypsin-treated erythrocytes, as well as dot blotting of endob-galactosidase-treated band 3 glycoprotein. Lactose significantly inhibited the agglutination of human erythrocytes with anti-C. braakii O37 serum, which suggested that the N-glycan of band 3, which consists of a long chain of poly-N-acetyllactosamine, may carry the common epitope. Moreover, in dot blotting, antibodies interacted more strongly with untreated than with endo-b-galactosidasetreated band 3. Endo-b-galactosidase specifically cleaves the poly-N-acetyllactosaminyl sugar chains of band 3 (Ando et al., 1996) . Therefore, these experiments indicated that the N-glycan of band 3 plays a role in this cross-reactivity. Band 4.1 also participates in this reactivity because a separate population of anti-C. braakii O37 antibodies, eluted by 1 M NaCl from the lipopolysaccharide affinity column, interacted specifically with band 4.1, but not with band 3. Protein 4.1 is essential for maintaining erythrocyte shape by interacting with band 3 and other membrane proteins (Nunomura & Takakuwa, 2006) .
Treatment of red cells with trypsin generated a 60-kDa fragment from band 3, as seen in SDS-PAGE. In immunoblotting, anti-C. braakii O37 antibodies (LPS-Abs, LPS96Abs) recognized the intact band 3 and slightly interacted with its 40-kDa fragment and, at the same time, did not recognize any other trypsin-elaborated band 3 fragments. The lack of binding to the 60-kDa tryptic fragments of band 3 is interesting, because the 40-kDa fragment contains all or most of the carbohydrates of band 3 (Drickamer, 1978; Fukuda et al., 1979) . These results indicated that the epitope is located on the carbohydrate domain of band 3. Anti-C. braakii O37 antibodies seemed to identify a common epitope on the poly-N-acetyllactosaminyl sugar chains of band 3 and not the ABO blood group epitopes, because the same intensity of reactivity was obtained for different blood groups in immunoblotting and ELISA tests. Therefore, the epitope on the human erythrocyte membrane is ABO blood group independent. Band 3 plays the key role in the recognition process and phagocytic removal of senescent erythrocytes (Arese et al., 2005) ; therefore, the autoantibodies recognize epitopes on both the polypeptide chain (Kay, 1993) and the carbohydrate domain of band 3 (Ando et al., 1996) . The collective data of this study indicated that the monospecific anti-C. braakii O37 antibodies interacted with the N-linked sugar chain of the band 3 glycoprotein, or with the glycopeptidic epitope of band 3, in which the oligosaccharide chain plays an essential role. Band 3 contains at a single N-glycosylation site the polylactosaminyl structure either as an elongated chain or a shorter, complex structure resulting in band 3 heterogeneity (Reithmeier, 1993, and refs cited) . It cannot be excluded, however, that the other type of glycan contributes into some degree to band 3 microheterogeneity. Further investigations are in progress in the authors' laboratory to determine the structure of this epitope, and these studies are focused not only on lipopolysaccharide core oligosaccharide but also concern band 3 protein.
Another distinct population of antibodies was also identified and isolated from anti-C. braakii O37 serum, by use of an affinity column with immobilized glycophorin A (Ebaid, 2007) . This minor antibody population recognized a trypsin-sensitive epitope on GPA. This epitope located on GPA was not recognized by the LPS-Abs antibody. Glycophorin A is a complex antigen of human erythrocytes carrying glycopeptidic epitopes (Lisowska, 2002) .
